Genizon BioSciences Publishes Genes for Crohn's Disease
News Sep 10, 2007
Genizon BioSciences has announced publication in this week's Proceedings of the National Academy of Sciences of four novel loci in Crohn's disease, in addition to confirmation of three known Crohn's disease genes. These discoveries are derived from a genome-wide association study in the Quebec Founder Population, which provides an advantage for comprehensive discovery of disease genes in complex disorders.
The new discoveries are expected to lead to the development of novel and more effective treatments for this disease.
Crohn's disease is an inflammatory bowel disorder with a strong genetic component. Diet and environment are also contributing factors. These complex origins have made it difficult for scientists to pinpoint the best targets for drug therapy.
"These discoveries were made in 2004 when we conducted the world's first comprehensive genome-wide association study for a common disease," commented Dr. John Hooper, CEO of Genizon.
"We have done a great deal of research and analysis since then, culminating in this publication and also leading to a comprehensive "GeneMap" of gene-gene interactions and biochemical pathways. We believe Genizon is the first organization to identify a large number of interacting genes that are linked to the root cause of a common disease."
The discoveries featured in the PNAS publication were replicated and refined in two German populations, demonstrating the applicability of findings in the Quebec Founder Population to general patient populations. The study includes large scale sequencing and maps explaining how the multiple susceptibility loci interact to result in disease.
Genizon has identified additional genes that complement the genes in the PNAS article. These and their interactions are also under study for the development of novel treatments for Crohn's disease.
New Cell-weighing Technique Helps Predict How Drugs Affect Cancer CellsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE